Zobrazeno 1 - 10
of 86
pro vyhledávání: '"AM Looney"'
Autor:
Deirdre M. Murray, Gerard W. O'Keeffe, Sophie Casey, AM Looney, L. McCowan, Vicki Livingstone, Fergus P. McCarthy, Rennae S. Taylor, John M. D. Thompson, Louise C. Kenny, Gerry Moloney, M. Carter
Publikováno v:
Journal of Autism and Developmental Disorders. 52:3919-3932
Autism spectrum disorder (ASD) is a developmental disorder characterised by deficits in social interactions and communication, with stereotypical and repetitive behaviours. Recent evidence suggests that maternal immune dysregulation may predispose of
Autor:
AM Looney, Gary P. Brennan, Geraldine B. Boylan, Sophie Casey, Dimitrios Vitsios, Deirdre M. Murray, David C. Henshall, Boubou Hallberg, Catherine Mooney
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 12, p e0207952 (2018)
PLoS ONE, Vol 13, Iss 12, p e0207952 (2018)
MicroRNAs are a class of small non-coding RNA that regulate gene expression at a post-transcriptional level. MicroRNAs have been identified in various body fluids under normal conditions and their stability as well as their dysregulation in disease h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::880d6b32bd4cdf5d8ca5b662e124b042
Autor:
Geraldine B. Boylan, Marc Paul O'Sullivan, Boubou Hallberg, Deirdre M. Murray, U. Felderhoff-Mueser, AM Looney, Caroline Ahearne, Mikael Finder
Publikováno v:
Molecular neurobiology. 56(5)
Hypoxic-ischaemic encephalopathy (HIE) remains one of the leading causes of neurological disability worldwide. No blood biomarker capable of early detection and classification of injury severity in HIE has been identified. This study aimed to investi
Publikováno v:
Europe PubMed Central
Human microRNA miR-374a is downregulated in the umbilical cord blood (UCB) of infants with hypoxic-ischaemic encephalopathy (HIE). The downstream targets of this microRNA (miRNA) are unclear, but one putative target is the activin-A receptor type IIb
Autor:
Mooney, Catherine, AM Looney, E Jimenez-Mateos, A Sanz Rodriguez, B Hallberg, DC Henshall, DM Murray, GB Boylan
Poster presented at the inaugural INFANT research day - June 16, 2015, Cork University Maternity Hospital, Cork IrelandSeizures are more common in the neonatal period than at any other time of life and are linked to poor neurological outcomes includi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11125eec820b541bfdf211c90c7ade77
Publikováno v:
Clinical Biochemistry. 46:1857-1859
The need for early and accurate prediction of outcome in hypoxic-ischaemic encephalopathy (HIE) remains critical. We have previously demonstrated that Interleukin 16 (IL-16) is raised in the umbilical cord blood (UCB) of infants with moderate and sev
Autor:
Gerard W. O'Keeffe, Deirdre M. Murray, Ailis Fagan, Gerard Clarke, John F. Cryan, Ted Dinan, Geraldine B. Boylan, Brian H. Walsh, Gerard M. Moloney, AM Looney, Sue Grenham
Publikováno v:
The Journal of pediatrics. 167(2)
Objective To investigate the expression profile of microRNA (miRNA) in umbilical cord blood from infants with hypoxic ischemic encephalopathy (HIE). Study design Full-term infants with perinatal asphyxia were identified under strict enrollment criter
Publikováno v:
Archives of Disease in Childhood. 97:A304-A305
Background/Aim Encephalopathy following severe neonatal asphyxia is one of the leading causes of morbidity and mortality in term neonates. Therapeutic hypothermia has been shown to improve outcomes in moderate and severe encephalopathy if administere
Autor:
Geraldine B. Boylan, Brian H. Walsh, Gerard Clarke, Sue Grenham, AM Looney, Ted Dinan, Gerry Moloney, Deirdre M. Murray, John F. Cryan
Publikováno v:
Archives of Disease in Childhood. 99:A165.3-A166
Background To guide the neuroprotective management of infants with hypoxic ischaemic encephalopathy (HIE), early identification is essential. MicroRNAs are small non-coding RNA molecules with potential for use as biological markers for disease. The a
Publikováno v:
Archives of Disease in Childhood. 99:A166.1-A166
Background Hypoxicischaemic encephalopathy (HIE) remains one of the leading causes of neonatal morbidity and mortality. Therapeutic hypothermia may improve the outcome of infants with moderate/severe encephalopathy but only if initiated within six ho